Buy or sell Ancora Heart stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Ancora Heart Stock

Ancora Heart is dedicated to helping people with heart failure feel better and live longer.

About Ancora Heart Stock

Ancora Heart is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an investigational therapy designed to repair the enlarged left ventricle targeting the underlying cause of heart failure. The AccuCinch heart failure treatment was created to benefit the millions of patients who otherwise have no minimally invasive option available to them.

Funding History

April 2010$30.0M
May 2018$17.8M
December 2018$23.5M
July 2021$80.0M

Management

Board Observer

Naveen Yalamanchi

President and CEO

Jeffrey M. Closs

Vice President, Clinical Marketing

Bart Beasley

CTO

Russel Sampson

Vice President, Regulatory Affairs and Quality Assurance

Mike Fritz

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo